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 Introduction: Acute Pancreatitis causes severe and persistent pain, and 
thus, necessitates effective treatment. Opioids are widely used to relieve 
pain in acute pancreatitis due to their efficacy and effectiveness. 
Intravenous paracetamol has been documented to have comparable 
effectiveness as that of opioids, with lesser side effects. In this study, the 
analgesic efficacy of tramadol, an opioid was compared with paracetamol 
in acute pancreatitis. 
 
Method: This was an open label comparative study conducted in a 
tertiary referral hospital of Nepal. Patients with Acute Pancreatitis were 
randomly assigned to receive 1 g of paracetamol or 50 mg of tramadol 
with 100 mL normal saline within 4-5 minute. Pain measurements of the 
patients were conducted at baseline and 24 hours after the treatment 
intervention. Changes in pain scores were calculated by subtracting the 
mean scores at baseline and 24 hours as pairs. 
 
Result: In this study, 80 patients were enrolled and included in the final 
analysis. The study subjects had a mean age of 39.33 +/- 13.3 years and 
62(77.5%) of them were male. Alcohol was the etiology for pancreatitis in 
67.5% (n=54) of patients. Mean pain scores at baseline and 24 hours 
were similar in the two groups. Similarly, change of scores from baseline 
to 24 hours did not differ between the groups. Comparison of pain 
improvements failed to reveal any differences between groups. 
 
Conclusion: Intravenous paracetamol is an effective alternative to 
tramadol in pain management of acute pancreatitis. 
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Introduction 
 
Acute pancreatitis is an acute inflammatory 
condition of the pancreas.1 It generally causes 
severe and persistent pain, and thus, 
necessitates effective pain management.2  
 
Consensus has not yet been reached as to 
which analgesics are useful in treating pain in 
patients with acute pancreatitis.2 Opioids are 
commonly used to manage such pain, 
although some of its clinical effectiveness and 
safety are still debatable.1,2 On the other 
hand, intravenous paracetamol is a 
cyclooxygenase inhibitor that has been 
documented to have comparable 
effectiveness with opioids in an emergency 
setting, and in various acute pain patterns.3,4 
However, the efficacy of intravenous 
paracetamol, and whether it is a suitable 
alternative to opioids is still a subject of 
research. A study from Western Nepal 
demonstrated that IV paracetamol has better 
analgesic effect compared to IV diclofenac.5 
 
In this study, the analgesic efficacy of 
tramadol, a synthetic opioid, was compared 






This was an open label randomized study 
conducted from August 2019 to January 2020 
in Gastroenterology Unit of Bir Hospital, 
National Academy of Medical Sciences 
(NAMS), Nepal. Ethical approval was obtained 
from the institutional review board (IRB) of 
NAMS. The trial was registered in the 
University hospital Medical Information 
Network (UMIN), Japan database UMIN-
000037790 (https://www.umin.ac.jp/ctr/index.htm). 
  
Patients of age 18 years or older, with 
diagnosis of Acute Pancreatitis, irrespective of 
severity were included in the study after 
informed consent. Acute pancreatitis was 
diagnosed according to the revised Atlanta 
Classification 2012, which requires that two or 
more of the following criteria be met for 
the diagnosis: (a) abdominal pain suggestive 
of pancreatitis, (b) serum amylase or lipase 
level greater than three times the upper 
normal value, or (c) characteristic imaging 
findings. Patients with severe hepatic 
impairment, severe renal impairment 
(CrCl<30ml/min), ongoing treatment with 
NSAIDs (within 24 hours), history of allergy to 
paracetamol, and/or tramadol were excluded 
from the study. Clinical, epidemiological, 
baseline laboratory and radiographic data- 
Ultrasonography (USG) Abdomen, Chest x-ray, 
CT Abdomen (if done) were collected by 
interview method by researchers. 
 
A sealed envelope method was used for 
randomization to assign eligible patients to 
one of the two treatment groups in 1:1 ratio. 
All the patients received standard medical 
treatment including early IV hydration, 
nutritional support, pain control and 
treatment of underlying issues. For pain 
control, participants were intravenously 
administered either 1000 mg paracetamol, or 
50 mg tramadol in 100 mL NS within 4-5 
minutes as dictated by the study group. 
Patients with inadequate pain relief (visual 
analog scale of ≥5) at 24 hours were 
administered intramuscular injection 
pethidine 25 mg as a rescue drug. Patients 
were discharged once they could tolerate oral 
feeding and became pain free. 
 
A 10 cm visual analog scale (VAS) displaying 
numbers between 0 and 10 (0 cm, no pain 
and 10 cm, worst pain) was used to measure 
pain intensity. Pain measurement of the 
patients was conducted at baseline (just 
before administering the drug) and 24 hours 
after the treatment intervention. Patients 
were blinded to previous VAS scores. Patients 
were also asked if they required rescue drug 
at the end of the study. Adverse effects, such 
as allergic reaction, nausea and vomiting, and 
others reported by participants, were also 
recorded. Patients with nausea and vomiting 
were treated with antiemetics and the study 
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The primary objective was to compare the 
efficacy of intravenous paracetamol with 
tramadol for pain management in acute 
pancreatitis. The secondary objective was to 
determine number of patients with drug-
related adverse events, causes of acute 
pancreatitis, and impact of two drugs on 
duration of hospital stay. We also tried to 
analyze incidence of severity of acute 
pancreatitis as per the revised Atlanta 
Classification.6 
 
By considering that the difference of less than 
10% is of no clinical significance, and the non-
inferiority margin of -0.1, the sample size was 
calculated by using the mean response rates 
of tramadol (90%) and paracetamol (80%) in 
the study done by Gulen B et al.7 It was 
calculated that a total 78 patients (39 in ach 
arm) would be required for the analysis with 
an alpha error at 0.05 and the power of study 
at 80%.  
 
We used intention-to-treat analysis for all 
efficacy analyses, analyzing all participants 
who underwent randomization. Continuous 
variables were expressed as mean ± standard 
deviation (SD) and categorical variables as 
numbers and frequencies. Categorical 
variables were compared using descriptive 
statistics and continuous variables with 
independent t test. Bivariate analysis was 
carried out to assess efficacy of two drugs. All 
statistical analyses were performed using the 





A total of 80 patients were included in the 
study with 40 in each group, Figure 1. 
 
The study period was of six months, from 
August 2019 to January 2020. The patients 
had a mean age of 39.33 +/- 13.3 years and 
77.5% (n=62) were male. Furthermore, in 
majority (67.5%, n=54) of the patients alcohol 
was the cause of pancreatitis, documented 
gallstones and biliary etiology for pancreatitis 
was seen in 11.25% (n=9) of the patients, 
biliary plus alcohol was seen in 2.5% (n=2), 
hypertriglyceridemia, post ERCP pancreatitis 
and Intrapapillary Mucinous Neoplasm (IPMN) 
were seen in 1 each, and unknown cause was 
seen in 15% (n=12). 
 
 
Table 1. Baseline characteristics of the patients with acute pancreatitis (AP), N = 80 
 
 
Mean Age +/- SD 39.33+/-13.4          
Gender –Male n (%)                    62 (77.5)    
Clinical symptoms and signs n (%)  
Nausea 50 (62.5%) 
Vomiting 42 (52.5%) 
Abdominal Tenderness 26 (32.5%) 
Guarding 5 (6.3%) 
Muscle rigidity 0 (0%) 
Etiology for pancreatitis n (%)  
Alcohol 54 (67.5%) 
Biliary 9 (11.25%) 
Others  17 (21.25%) 
Severity of AP as per revised Atlanta Classification  
Acute 50 (62.5%) 
Moderately severe 22 (27.5) 
Severe 8 (10) 
 
 
As per the revised Atlanta classification6, 50 
(62.5%) had mild acute pancreatitis, Table 1.  
 
 
When compared in both the groups, the 
distribution of mild, moderate and severe 
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Figure 1. Flow Diagram of the participants in the study 
 
 
Table 2. Change in pain intensity at baseline and 24 h for each group of patients with acute pancreatitis (AP) 
 
 
Variable Paracetamol Group Tramadol Group  p value 
Baseline VAS (mean) 7.6 7.93  
24 Hours VAS (mean) 0.98 1.43  
Change from Baseline (mean) 6.63 6.5 0.691 
VAS: visual analogue scale 
 
Table 3. Adverse effects in two treatment groups in patients with acute pancreatitis (AP) 
 
 
Variables  Paracetamol 
 N (%)  
Tramadol  
N (%)  
Allergic reaction (urticaria or itching)  0 (0%) 0 (0%) 
Giddiness 0 (0%) 0 (0%) 
Nausea and vomiting  0 (0%) 1 (2.5%) 
Sedation  0 (0%) 0 (0%) 
Others 0 (0%) 0 (0%) 
 
Table 4. Hospital stay in two treatment groups in patients with acute pancreatitis (AP) 
 
 
 Paracetamol Tramadol p value 
Number of patients 40 40  




The changes in pain scores were calculated by 
subtracting the mean scores at baseline and 
24 hours as pairs. According to the 
comparison of pain improvements, there was 
no significant difference between the two 
groups, Table 2.  
 
Two (2.5%) in the paracetamol group, and one 
(1.25%) in the tramadol group required the 
administration of a rescue drug (Inj 
pethidine). Nausea and vomiting were  
 
reported by 1.25% of patients in the tramadol 
group and it was not reported in the 
paracetamol group. None of the side effects 
like sedation, giddiness occurred in patients in 





Our study demonstrated that there was no 
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paracetamol with regards to analgesic efficacy 
in acute pancreatitis. The finding of this study 
is consistent with the study done by Gülen B 
et al7 and various other studies which 
compared the efficacy of paracetamol with 
tramadol in various pain patterns.8,9 
 
The most common etiology of acute 
pancreatitis in our study was alcohol (67.5%). 
It was different from Turkish study where 
alcohol accounted for only 21.1%, and 73.3% 
had gallstones and biliary pancreatitis.6 In 
another study done by Zheng Y et al from 
China, alcohol was responsible for only 10% of 
cases of acute pancreatitis.10 The 
predominance of alcohol induced pancreatitis 
in our study may be attributable to higher 
number of male patients. The male 
population are likely to consume more alcohol 
in our culture, which has been shown by a 
study by Maharjan P et al.11 
 
In our study, one (2.5%) patient each in 
tramadol and paracetamol group required 
administration of rescue drug. This is much 
less than rescue medications required in a 
study by Gullen B et al. in which four (13.3%) 
in the paracetamol group, and three (10%) in 
the tramadol group required administration 
of a rescue drug.6 This may be attributable to 
relatively less number of patients with severe 
disease (10%) in our study. 
 
Gulen et al. compared the efficacy of both the 
drugs in the pain management of acute 
pancreatitis and found them to be at par. 
They found that one patient in paracetamol 
group and two patients in tramadol group had 
nausea and vomiting which was statistically 
insignificant, and is similar to our findings. In 
our study, adverse effects of tramadol were 
also not as high as reported in other studies.12 
 
In patients with severe disease (persistent 
organ failure), who account for about 20% of 
presentations, mortality is approximately 
30%.13 But there was no mortality in our 
study. Majority of the patients in our study 
were relatively young (mean age 39.9 years) 
and 90% had mild or moderately severe 
disease; these factors could have led to the 
improved survival in our patients. 
 
In our study, hospital stay was lesser in 
patients in paracetamol group as compared to 
tramadol group (mean hospital stays 4.85 vs 
6.8 days), however, this difference was not 
statistically significant (p=0.089), Table 4. A 
study by Mohammed S et al. reported that 
lesser adverse effects with paracetamol use 
compared to tramadol translates into the 
lesser duration of hospitalization and hence 
earlier discharge.9 However, adverse effects 
associated with tramadol use was not 
common in our study.  
 
There are some limitations of our study. This 
was a single center study with a small sample 
size and was not blinded. This study showed 
that tramadol is not superior to paracetamol 
in relieving pain in acute pancreatitis; 
however, this does not mean these two drugs 
have the same efficacy. A larger sample size 
would be needed to test the hypothesis that 
intravenous tramadol and paracetamol are 
equally effective in relieving pain in acute 
pancreatitis (an equivalence trial). Moreover, 
study patients had different etiologies of 
acute pancreatitis, which may also have had 






The intravenous paracetamol is an effective 
alternative to tramadol in pain management 




We acknowledge all the residents of 
Gastroenterology Unit of Bir Hospital who 
have helped during data acquisition and all 
the staff of our department for their 
assistance during the study period. 
 
 







Roshan Shrestha: Paracetamol vs tramadol in acute pancreatitis 





All authors made substantial intellectual 
contributions to the study. RS: Provided the 
conception and design of the study, 
acquisition of data, analysis and 
interpretation of data, drafting the article, 
revised it critically for important intellectual 
content, and final approval of the version to 
be submitted. SK: Supplied the acquisition of 
data, drafting of manuscript. MS: Supplied the 
design of study, analysis and interpretation. 
NP: Responsible for revising the article 
critically for important intellectual content. 
AK: Revised the article critically for important 
intellectual content and gave final approval of 





1. Swaroop VS, Chari ST, Clain JE. Severe acute 
pancreatitis. JAMA. 2004;291(23):2865-8. DOI 
| PubMed | GoogleScholar 
2. Yokoe M, Takada T, Mayumi T, Yoshida M, 
Isaji S, Wada K, et al. Japanese guidelines for 
the management of acute pancreatitis: 
Japanese Guidelines 2015. J Hepatobiliary 
Pancreat Sci. 2015;22(6):405-32. DOI | 
PubMed | GoogleScholar | WebLink PDF 
3. Eken C, Serinken M, Elicabuk H, Uyanik 
E, Erdal M. Intravenous paracetamol versus 
dexketoprofen versus morphine in acute 
mechanical low back pain in the emergency 
department: a randomised double-blind 
controlled trial. Emerg Med J. 2014;31(3):177-
81. DOI | PubMed | GoogleScholar | PDF 
4. Serinken M, Eken C, Turkcuer I, Elicabuk H, 
Uyanik E, Schultz CH. Intravenous paracetamol 
versus morphine for renal colic in the 
emergency department: a randomised 
double-blind controlled trial. Emerg Med 
J. 2012;29(11):902-5. DOI | PubMed | 
GoogleScholar 
5. Kharbuja K, Sharma M, Sharma NR. 
Comparative evaluation of effectiveness of 
intravenous paracetamol and intravenous 
diclofenac as post-operative analgesia in 
laparoscopic cholecystectomy. J Lumbini Med 
Coll. 2018;6(2):73-8. DOI  GoogleScholar   
PDF | WebLink 
6. Banks PA, Bollen TL, Dervenis C, Gooszen HG, 
Johnson CD, Sarr MG, Tsiotos GG, Vege SS. 
Classification of acute pancreatitis-2012: 
revision of the Atlanta classification and 
definitions by international consensus. Gut. 
2013;62(1):102-11. DOI | PubMed | 
GoogleScholar | PDF 
7. Gülen B, Dur A, Serinken M, Karcioglu O, 
Sonmez E. Pain treatment in patients with 
acute pancreatitis: a randomized controlled 
trial. Turk J Gastoenterol. 2016;27(2):192-6. 
DOI | PubMed | GoogleScholar 
8. Kaur MJ, Jain K, Bhatia N, Jain V, Mal MS. 
Comparison of analgesic efficacy of 
paracetamol and tramadol for pain relief in 
active labor. J Clin Anesth. 2015;2:159-63. DOI 
|  PubMed | GoogleScholar 
9. Shahid M, Manjula BP, Sunil BV. A 
comparative study of intravenous 
paracetamol and intravenous tramadol for 
postoperative analgesia in laparotomies. 
Anesth Essays Res. 2015;9(3):314-9. DOI | 
PubMed | GoogleScholar 
10. Zheng Y, Zhou Z, Li H, Li J, Li A, Ma B, et al. A 
multicenter study on etiology of acute 
pancreatitis in Beijing during 5 years. 
Pancreas. 2015;44(3):409-14. DOI | PubMed | 
GoogleScholar 
11. Maharjan PL, Magar KT. Prevalence of alcohol 
consumption and factors associated with the 
alcohol use among the youth of Suryabinayak 
Municipality, Bhaktapur. J Pharma Care Health 
Sys. 2017;4:1. DOI GoogleScholar PDF 
WebLink 
12. Langley PC, Patkar AD, Boswell KA, Benson CJ, 
Schein JR. Adverse event profile of tramadol in 
recent clinical studies of chronic osteoarthritis 
pain. Curr Med Res Opin. 2010;26(1):239-51. 
DOI | PubMed | GoogleScholar 
13. Whitcomb DC. Acute Pancreatitis. N Engl J 
Med.2006;354(20):2142-50. DOI| PubMed | 
Weblink
 
 
 
